All Stories

  1. Data from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  2. Data from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  3. Supplementary Figure S1 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  4. Supplementary Figure S1 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  5. Supplementary Figure S2 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  6. Supplementary Figure S2 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  7. Supplementary Figure S3 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  8. Supplementary Figure S3 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  9. Supplementary Figure S4 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  10. Supplementary Figure S4 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  11. Supplementary Figure S5 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  12. Supplementary Figure S5 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  13. Supplementary Table S1 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  14. Supplementary Table S1 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  15. Supplementary Table S2 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  16. Supplementary Table S2 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  17. Supplementary Table S3 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  18. Supplementary Table S3 from Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer

    Article • January 2024, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  19. Data from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  20. Data from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  21. Supplementary Figure 1 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  22. Supplementary Figure 1 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  23. Supplementary Figure 2 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  24. Supplementary Figure 2 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  25. Supplementary Figure 3 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  26. Supplementary Figure 3 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  27. Supplementary Figure 4 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  28. Supplementary Figure 4 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  29. Supplementary Figure 5 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  30. Supplementary Figure 5 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  31. Supplementary Figure 6 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  32. Supplementary Figure 6 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  33. Supplementary Figure 7 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  34. Supplementary Figure 7 from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  35. Supplementary Information from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  36. Supplementary Information from Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  37. Prostate cancer progression relies on the mitotic kinase citron kinase

    Article • Cancer Research, October 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  38. Targeting NANOG and FAK via Cx26-derived cell-penetrating peptides in triple-negative breast cancer

    Article • Molecular Cancer Therapeutics, September 2023, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  39. Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes

    Article • European Urology Open Science, December 2020, Elsevier

    Dr Salma Ben-Salem

  40. Abstract 390: Prostate cancer progression depends on the activity of the mitotic kinase citron kinase

    Article • Cancer Research, July 2019, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  41. Abstract 390: Prostate cancer progression depends on the activity of the mitotic kinase citron kinase

    Article • July 2019, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  42. Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy

    Article • Oncogene, February 2019, Springer Science + Business Media

    Dr Salma Ben-Salem

  43. Abstract 3745: Inhibition of Protein Kinase N1 prevents control of AR over SRF action in advanced prostate cancer

    Article • Cancer Research, July 2018, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  44. Abstract LB-211: The cardiac transcription factor Nkx2-5 contributes to SRF-dependent AR action in prostate cancer

    Article • Cancer Research, July 2018, American Association for Cancer Research (AACR)

    Dr Salma Ben-Salem

  45. A B3GALT6 variant in patient originally described as Al‐Gazali syndrome and implicating the endoplasmic reticulum quality control in the mechanism of some β3GalT6‐pathy mutations

    Article • Clinical Genetics, March 2018, Wiley

    Dr Salma Ben-Salem

  46. Compound heterozygous variants in the multiple PDZ domain protein (MPDZ) cause a case of mild non-progressive communicating hydrocephalus

    Article • BMC Medical Genetics, March 2018, Springer Science + Business Media

    Dr Salma Ben-Salem

  47. Defect in phosphoinositide signalling through a homozygous variant inPLCB3causes a new form of spondylometaphyseal dysplasia with corneal dystrophy

    Article • Journal of Medical Genetics, November 2017, BMJ

    Dr Salma Ben-Salem

  48. A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer

    Article • eLife, August 2017, eLife

    Dr Salma Ben-Salem

  49. A homozygous splicing mutation in ELAC2 suggests phenotypic variability including intellectual disability with minimal cardiac involvement

    Article • Orphanet Journal of Rare Diseases, October 2016, Springer Science + Business Media

    Dr Salma Ben-Salem

  50. Cover Image, Volume 170A, Number 8, August 2016

    Article • American Journal of Medical Genetics Part A, July 2016, Wiley

    Dr Salma Ben-Salem

  51. A recessive syndrome of intellectual disability, moderate overgrowth, and renal dysplasia predisposing to Wilms tumor is caused by a mutation inFIBPgene

    Article • American Journal of Medical Genetics Part A, May 2016, Wiley

    Dr Salma Ben-Salem

  52. Gonadal mosaicism in ARID1B gene causes intellectual disability and dysmorphic features in three siblings

    Article • American Journal of Medical Genetics Part A, September 2015, Wiley

    Dr Salma Ben-Salem

  53. A Novel Single-Nucleotide Deletion (c.1020delA) in NSUN2 Causes Intellectual Disability in an Emirati Child

    Article • Journal of Molecular Neuroscience, June 2015, Springer Science + Business Media

    Dr Salma Ben-Salem

  54. A novel splice site deletion in the OFD1 gene is responsible for oral–facial–digital syndrome type1 in an Emirati child

    Article • Hamdan Medical Journal, May 2015, Hamdan Medical Journal

    Dr Salma Ben-Salem

  55. New Arab family with cerebral dysgenesis, neuropathy, ichthyosis and keratoderma syndrome suggests a possible founder effect for the c.223delG mutation

    Article • The Journal of Dermatology, May 2015, Wiley

    Dr Salma Ben-Salem

  56. A Novel Whole Exon Deletion in WWOX Gene Causes Early Epilepsy, Intellectual Disability and Optic Atrophy

    Article • Journal of Molecular Neuroscience, November 2014, Springer Science + Business Media

    Dr Salma Ben-Salem

  57. Transaldolase deficiency caused by the homozygous p.R192C mutation of the TALDO1 gene in four Emirati patients with considerable phenotypic variability

    Article • European Journal of Pediatrics, November 2014, Springer Science + Business Media

    Dr Salma Ben-Salem

  58. Mutation spectrum of Joubert syndrome and related disorders among Arabs

    Article • Human Genome Variation, November 2014, Springer Science + Business Media

    Dr Salma Ben-Salem

  59. Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay

    Article • Metabolic Brain Disease, September 2014, Springer Science + Business Media

    Dr Salma Ben-Salem

  60. Identification of the Cellular Mechanisms That Modulate Trafficking of Frizzled Family Receptor 4 (FZD4) Missense Mutants Associated With Familial Exudative Vitreoretinopathy

    Article • Investigative Ophthalmology & Visual Science, June 2014, Association for Research in Vision and Ophthalmology (ARVO)

    Dr Salma Ben-Salem

  61. METTL23, a transcriptional partner of GABPA, is essential for human cognition

    Article • Human Molecular Genetics, February 2014, Oxford University Press (OUP)

    Dr Salma Ben-Salem

  62. The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE

    Article • Child s Nervous System, January 2014, Springer Science + Business Media

    Dr Salma Ben-Salem

  63. Analysis of two Arab families reveals additional support for a DFNB2 nonsyndromic phenotype of MYO7A

    Article • Molecular Biology Reports, November 2013, Springer Science + Business Media

    Dr Salma Ben-Salem

  64. Determination of the CCR5∆32 frequency in Emiratis and Tunisians and the screening of the CCR5 gene for novel alleles in Emiratis

    Article • Gene, October 2013, Elsevier

    Dr Salma Ben-Salem

  65. Posterior microphthalmia and nanophthalmia in Tunisia caused by a founder c.1059_1066insC mutation of the PRSS56 gene

    Article • Gene, October 2013, Elsevier

    Dr Salma Ben-Salem

  66. Novel mutations in ADAMTSL2 gene underlying geleophysic dysplasia in families from United Arab Emirates

    Article • Birth Defects Research Part A Clinical and Molecular Teratology, September 2013, Wiley

    Dr Salma Ben-Salem

  67. Mutations in DDHD2, Encoding an Intracellular Phospholipase A1, Cause a Recessive Form of Complex Hereditary Spastic Paraplegia

    Article • The American Journal of Human Genetics, December 2012, Elsevier

    Dr Salma Ben-Salem, Martin Lammens

  68. Clinical and molecular analysis of isovaleric acidemia patients in the United Arab Emirates reveals remarkable phenotypes and four novel mutations in the IVD gene

    Article • European Journal of Medical Genetics, December 2012, Elsevier

    Dr Salma Ben-Salem

  69. A Novel Aberrant Splice Site Mutation in RAB23 Leads to an Eight Nucleotide Deletion in the mRNA and Is Responsible for Carpenter Syndrome in a Consanguineous Emirati Family

    Article • Molecular Syndromology, January 2012, Karger Publishers

    Dr Salma Ben-Salem

  70. Alteration of the serine protease PRSS56 causes angle-closure glaucoma in mice and posterior microphthalmia in humans and mice

    Article • Nature Genetics, May 2011, Springer Science + Business Media

    Dr Salma Ben-Salem

  71. A genome-wide linkage scan in Tunisian families identifies a novel locus for non-syndromic posterior microphthalmia to chromosome 2q37.1

    Article • Human Genetics, June 2009, Springer Science + Business Media

    Dr Salma Ben-Salem, Dr Ahmed Rebai